{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:31:00Z","timestamp":1790227860461,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11983-6","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T11:03:53Z","timestamp":1756465433000},"page":"2317-2328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["One-year outcomes of glue prostate-artery-embolization for symptomatic benign prostatic hyperplasia: a single-center retrospective cohort study"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3107-5967","authenticated-orcid":false,"given":"Romaric","family":"Loffroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Quirantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto Taninokuchi","family":"Tomassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Comby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig Serge","family":"Aho-Gl\u00e9l\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"11983_CR1","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/S0022-5347(05)00310-1","volume":"175","author":"AL Burnett","year":"2006","unstructured":"Burnett AL, Wein AJ (2006) Benign prostatic hyperplasia in primary care: what you need to know. J Urol 175:S19\u2013S24","journal-title":"J Urol"},{"key":"11983_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ucl.2021.12.003","volume":"49","author":"A Plochocki","year":"2022","unstructured":"Plochocki A, King B (2022) Medical treatment of benign prostatic hyperplasia. Urol Clin North Am 49:231\u2013238","journal-title":"Urol Clin North Am"},{"key":"11983_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/JU.0000000000001298","volume":"204","author":"JK Parsons","year":"2020","unstructured":"Parsons JK, Dahm P, K\u00f6hler TS, Lerner LB, Wilt TJ (2020) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment. J Urol 204:799\u2013804","journal-title":"J Urol"},{"key":"11983_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.crad.2019.12.019","volume":"75","author":"R Geevarghese","year":"2020","unstructured":"Geevarghese R, Harding J, Parsons N, Hutchinson C, Parsons C (2020) The relationship of embolic particle size to patient outcomes in prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-regression. Clin Radiol 75:366\u2013374","journal-title":"Clin Radiol"},{"key":"11983_CR5","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s00270-018-1912-5","volume":"41","author":"D Maclean","year":"2018","unstructured":"Maclean D, Harris M, Drake T et al (2018) Factors predicting a good symptomatic outcome after prostate artery embolisation (PAE). Cardiovasc Interv Radiol 41:1152\u20131159","journal-title":"Cardiovasc Interv Radiol"},{"key":"11983_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/bju.13147","volume":"117","author":"M Wang","year":"2016","unstructured":"Wang M, Guo L, Duan F et al (2016) Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates. BJU Int 117:155\u2013164","journal-title":"BJU Int"},{"key":"11983_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.euf.2018.09.005","volume":"5","author":"V Zumstein","year":"2019","unstructured":"Zumstein V, Betschart P, Vetterlein MW et al (2019) Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol Focus 5:1091\u20131100","journal-title":"Eur Urol Focus"},{"key":"11983_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.urology.2015.04.037","volume":"86","author":"GI Russo","year":"2015","unstructured":"Russo GI, Kurbatov D, Sansalone S et al (2015) Prostatic arterial embolization vs open prostatectomy: a 1-year matched-pair analysis of functional outcomes and morbidities. Urology 86:343\u2013348","journal-title":"Urology"},{"key":"11983_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00270-015-1202-4","volume":"39","author":"FC Carnevale","year":"2016","unstructured":"Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M (2016) Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): Preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Interv Radiol 39:44\u201352","journal-title":"Cardiovasc Interv Radiol"},{"key":"11983_CR10","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s00330-012-2714-9","volume":"23","author":"JM Pisco","year":"2013","unstructured":"Pisco JM, Rio Tinto H, Campos Pinheiro L et al (2013) Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: Results of short- and mid-term follow-up. Eur Radiol 23:2561\u20132572","journal-title":"Eur Radiol"},{"key":"11983_CR11","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1007\/s00330-020-07663-2","volume":"31","author":"P Xiang","year":"2021","unstructured":"Xiang P, Guan D, Du Z et al (2021) Efficacy and safety of prostatic artery embolization for benign prostatic hyperplasia: A systematic review and meta-analysis of randomized controlled trials. Eur Radiol 31:4929\u20134946","journal-title":"Eur Radiol"},{"key":"11983_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.diii.2023.01.012","volume":"104","author":"A Marchi","year":"2023","unstructured":"Marchi A, Pellerin O, Querub C et al (2023) Long-term outcomes of prostate artery embolization for acute urinary retention: an analysis of 88 patients. Diagn Interv Imaging 104:292\u2013296","journal-title":"Diagn Interv Imaging"},{"key":"11983_CR13","doi-asserted-by":"publisher","first-page":"k2338","DOI":"10.1136\/bmj.k2338","volume":"361","author":"D Abt","year":"2018","unstructured":"Abt D, Hechelhammer L, M\u00fcllhaupt G et al (2018) Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ 361:k2338","journal-title":"BMJ"},{"key":"11983_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/bju.14249","volume":"122","author":"AF Ray","year":"2018","unstructured":"Ray AF, Powell J, Speakman MJ et al (2018) Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int 122:270\u2013282","journal-title":"BJU Int"},{"key":"11983_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.eururo.2023.04.008","volume":"84","author":"S Gravas","year":"2023","unstructured":"Gravas S, Gacci M, Gratzke C et al (2023) Summary paper on the 2023 European Association of Urology guidelines on the management of non-neurogenic male lower urinary tract symptoms. Eur Urol 84:207\u2013222","journal-title":"Eur Urol"},{"key":"11983_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1148\/radiol.2016152292","volume":"281","author":"T Bilhim","year":"2016","unstructured":"Bilhim T, Pisco J, Pereira JA et al (2016) Predictors of clinical outcome after prostate artery embolization with spherical and non-spherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology 281:289\u2013300","journal-title":"Radiology"},{"key":"11983_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00330-024-10998-9","volume":"35","author":"T Bilhim","year":"2025","unstructured":"Bilhim T, Vasco Costa N, Torres D, Ak\u0131\u015f S, Alves M, Papoila AL (2025) Comparing embolic particles for prostatic artery embolization to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia. Eur Radiol 35:1057\u20131066","journal-title":"Eur Radiol"},{"key":"11983_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00261-017-1267-4","volume":"43","author":"G Abdulmalak","year":"2018","unstructured":"Abdulmalak G, Chevallier O, Falvo N et al (2018) Safety and efficacy of transcatheter embolization with Glubran\u00ae2 cyanoacrylate glue for acute arterial bleeding: a single-center experience with 104 patients. Abdom Radiol (NY) 43:723\u2013733","journal-title":"Abdom Radiol (NY)"},{"key":"11983_CR19","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s00330-020-07427-y","volume":"31","author":"R Loffroy","year":"2021","unstructured":"Loffroy R, Desmyttere AS, Mouillot T et al (2021) Ten-year experience with arterial embolization for peptic ulcer bleeding: N-butyl cyanoacrylate glue versus other embolic agents. Eur Radiol 31:3015\u20133026","journal-title":"Eur Radiol"},{"key":"11983_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2174\/157016109787455617","volume":"7","author":"R Loffroy","year":"2009","unstructured":"Loffroy R, Guiu B, Cercueil JP, Kraus\u00e9 D (2009) Endovascular therapeutic embolisation: An overview of occluding agents and their effects on embolised tissues. Curr Vasc Pharm 7:250\u2013263","journal-title":"Curr Vasc Pharm"},{"key":"11983_CR21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00270-022-03199-8","volume":"45","author":"T Bilhim","year":"2022","unstructured":"Bilhim T, Vasco Costa N, Torres D, Campos Pinheiro L, Spaepen E (2022) Long-term outcome of prostatic artery embolization for patients with benign prostatic hyperplasia: single-center retrospective study in 1072 patients over a 10-year period. Cardiovasc Intervent Radiol 45:1324\u20131336","journal-title":"Cardiovasc Intervent Radiol"},{"key":"11983_CR22","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.3390\/jcm10143161","volume":"10","author":"R Loffroy","year":"2021","unstructured":"Loffroy R, Guillen K, Salet E et al (2021) Prostate artery embolization using n-butyl cyanoacrylate glue for urinary tract symptoms due to benign prostatic hyperplasia: a valid alternative to microparticles?. J Clin Med 10:3161","journal-title":"J Clin Med"},{"key":"11983_CR23","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00270-022-03069-3","volume":"45","author":"E Salet","year":"2022","unstructured":"Salet E, Cromb\u00e9 A, Grenier N et al (2022) Prostatic artery embolization for benign prostatic obstruction: single-center retrospective study comparing microspheres versus n-butyl cyanoacrylate. Cardiovasc Intervent Radiol 45:814\u2013823","journal-title":"Cardiovasc Intervent Radiol"},{"key":"11983_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.diii.2023.12.006","volume":"105","author":"R Loffroy","year":"2024","unstructured":"Loffroy R, Quirantes A, Guillen K et al (2024) Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: a six-month outcome analysis in 103 patients. Diagn Interv Imaging 105:129\u2013136","journal-title":"Diagn Interv Imaging"},{"key":"11983_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvir.2020.100695","volume":"23","author":"S Young","year":"2020","unstructured":"Young S, Golzarian J (2020) Prostate artery embolization: state of the evidence and societal guidelines. Tech Vasc Interv Radiol 23:100695","journal-title":"Tech Vasc Interv Radiol"},{"key":"11983_CR26","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/S0022-5347(01)66780-6","volume":"154","author":"MJ Barry","year":"1995","unstructured":"Barry MJ, Williford WO, Chang Y et al (1995) Benign prostatic hyperplasia specific health status measures in clinical research: How much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?. J Urol 154:1770\u20131774","journal-title":"J Urol"},{"key":"11983_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","volume":"11","author":"RC Rosen","year":"1999","unstructured":"Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319\u2013326","journal-title":"Int J Impot Res"},{"key":"11983_CR28","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1097\/01.RVI.0000094584.83406.3e","volume":"14","author":"D Sacks","year":"2003","unstructured":"Sacks D, McClenny TE, Cardella JF, Lewis CA (2003) Society of Interventional Radiology Clinical Practice guidelines. J Vasc Interv Radiol 14:S199\u2013S202","journal-title":"J Vasc Interv Radiol"},{"key":"11983_CR29","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jvir.2017.06.019","volume":"28","author":"O Khalilzadeh","year":"2017","unstructured":"Khalilzadeh O, Baerlocher MO, Shyn PB et al (2017) Proposal of a new adverse event classification by the Society of Interventional Radiology standards of practice committee. J Vasc Interv Radiol 28:1432\u20131437.e3","journal-title":"J Vasc Interv Radiol"},{"key":"11983_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"key":"11983_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.diii.2022.09.007","volume":"103","author":"M Barat","year":"2022","unstructured":"Barat M, Jannot AS, Dohan A, Soyer P (2022) How to report and compare quantitative variables in a radiology article. Diagn Interv Imaging 103:571\u2013573","journal-title":"Diagn Interv Imaging"},{"key":"11983_CR32","unstructured":"Vach W (2013) The modern way of inference. C1 Robust estimation of standard errors. In: Regression models as a tool in medical research. CRC Press, Boca Raton, p 461"},{"key":"11983_CR33","doi-asserted-by":"publisher","first-page":"e032795","DOI":"10.1136\/bmjopen-2019-032795","volume":"9","author":"MH Blanker","year":"2019","unstructured":"Blanker MH, Alma HJ, Devji TS, Roelofs M, Steffens MG, van der Worp H (2019) Determining the minimal important differences in the International Prostate Symptom Score and Overactive Bladder Questionnaire: results from an observational cohort study in Dutch primary care. BMJ Open 23 9:e032795","journal-title":"BMJ Open 23"},{"key":"11983_CR34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/j.1464-410X.2010.09229.x","volume":"106","author":"RJ Hoekstra","year":"2010","unstructured":"Hoekstra RJ, Van Melick HHE, Kok ET, Ruud Bosch JLH (2010) A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: long-term results of a randomized controlled trial. BJU Int 106:822\u2013826","journal-title":"BJU Int"},{"key":"11983_CR35","first-page":"261","volume":"20","author":"BA Hijazi","year":"2023","unstructured":"Hijazi BA, Shi HB, Liu S, Alqurashi TA, Sabri ZJ (2023) N-butyl cyanoacrylate glue versus nonspherical polyvinyl alcohol particles for prostatic arterial embolization to treat benign prostatic hyperplasia: safety and efficacy. Urol J 20:261\u2013268","journal-title":"Urol J"},{"key":"11983_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00330-018-5564-2","volume":"29","author":"B Malling","year":"2019","unstructured":"Malling B, R\u00f8der MA, Brasso K, Forman J, Taudorf M, L\u00f6nn L (2019) Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol 29:287\u2013298","journal-title":"Eur Radiol"},{"key":"11983_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00270-016-1539-3","volume":"40","author":"M Kuang","year":"2017","unstructured":"Kuang M, Vu A, Athreya S (2017) A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia. Cardiovasc Interv Radiol 40:655\u2013663","journal-title":"Cardiovasc Interv Radiol"},{"key":"11983_CR38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jvir.2018.12.734","volume":"30","author":"A Moreira de Assis","year":"2019","unstructured":"Moreira de Assis A, Moreira AM, Carnevale FC (2019) Angiographic findings during repeat prostatic artery embolization. J Vasc Interv Radiol 30:645\u2013651","journal-title":"J Vasc Interv Radiol"},{"key":"11983_CR39","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jvir.2024.09.011","volume":"36","author":"R Loffroy","year":"2025","unstructured":"Loffroy R (2025) The concept of prostatic artery occlusion with cyanoacrylate glue: a potential game changer. J Vasc Interv Radiol 36:184","journal-title":"J Vasc Interv Radiol"},{"key":"11983_CR40","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.jvir.2024.07.018","volume":"35","author":"D Bamshad","year":"2024","unstructured":"Bamshad D, Sanghvi J, Galla N et al (2024) Early outcomes of prostate artery embolization using n-butyl cyanoacrylate liquid embolic: a safety and feasibility study. J Vasc Interv Radiol 35:1855\u20131861","journal-title":"J Vasc Interv Radiol"},{"key":"11983_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jmbbm.2017.01.003","volume":"69","author":"YJ Li","year":"2017","unstructured":"Li YJ, Barthes-Biesel D, Salsac AV (2017) Polymerization kinetics of n-butyl cyanoacrylate glues used for vascular embolization. J Mech Behav Biomed Mater 69:307\u2013317","journal-title":"J Mech Behav Biomed Mater"},{"key":"11983_CR42","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1007\/s00270-010-9863-5","volume":"33","author":"T Yonemitsu","year":"2010","unstructured":"Yonemitsu T, Kawai N, Sato M et al (2010) Comparison of hemostatic durability between N-butyl cyanoacrylate and gelatin sponge particles in transcatheter arterial embolization for acute arterial hemorrhage in a coagulopathic condition in a swine model. Cardiovasc Intervent Radiol 33:1192\u20131197","journal-title":"Cardiovasc Intervent Radiol"},{"key":"11983_CR43","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jvir.2022.01.014","volume":"33","author":"B Brown","year":"2022","unstructured":"Brown B, Yu H, Bagla S, Isaacson A (2022) Nontarget radiopaque embolic deposition during prostatic artery embolization. J Vasc Interv Radiol 33:558\u2013563.e1","journal-title":"J Vasc Interv Radiol"},{"key":"11983_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4081\/aiua.2018.1.40","volume":"90","author":"K Stamatiou","year":"2018","unstructured":"Stamatiou K (2018) The impact of prostate artery embolization (PAE) on the physical history and pathophysiology of benign prostatic hyperplasia (BPH). Arch Ital Urol 90:40\u201343","journal-title":"Arch Ital Urol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11983-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11983-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11983-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:02:43Z","timestamp":1772719363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11983-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["11983"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11983-6","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Romaric Loffroy, MD, PhD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"R.L. is a paid consultant for Guerbet and GEM. The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors is a methodologist\/statistician and provided significant statistical expertise: Ludwig Serge Aho-Gl\u00e9l\u00e9, MD, Department of Epidemiology, Statistics and Clinical Research, Fran\u00e7ois-Mitterrand University Hospital, Dijon, France.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this study, in accordance with French law on retrospective analyses of de-identified health data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Ethics committee submission and approval were not required for this study, in accordance with French law on analyses of de-identified health data.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The 186 patients included in this study are among the 103 patients included in a previous study reporting short-term follow-up by our group. Reference is as follows: \u201cLoffroy et al [\n                      \n                      ]\u201d.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}